Last update 01 Nov 2024

Pitavastatin Magnesium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Pitava, Pitavastatin, 匹伐他汀
+ [3]
Mechanism
HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (14 Jul 2017),
Regulation-
Login to view timeline

Structure

Molecular FormulaC50H46F2MgN2O8
InChIKeyMPAZKXHCZWDZDY-UHFFFAOYSA-L
CAS Registry956116-90-8

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hyperlipidemias
US
14 Jul 2017
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Primary hypercholesterolemiaPhase 1
RU
01 Sep 2005
Primary hypercholesterolemiaPhase 1
NL
01 Sep 2005
Primary hypercholesterolemiaPhase 1
GB
01 Sep 2005
Primary hypercholesterolemiaPhase 1
NO
01 Sep 2005
Primary hypercholesterolemiaPhase 1
FI
01 Sep 2005
Primary hypercholesterolemiaPhase 1
IL
01 Sep 2005
Primary hypercholesterolemiaPhase 1
SE
01 Sep 2005
Primary hypercholesterolemiaPhase 1
IT
01 Sep 2005
Primary hypercholesterolemiaPhase 1
ES
01 Sep 2005
Primary hypercholesterolemiaPhase 1
DK
01 Sep 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
602
(Pitavastatin)
dmmzazzwvl(gnhuvuehyr) = igaqiejkby bbvmmtfvvb (qyrmstyxfo, epwjodtlpp - pxorsijcwr)
-
28 Oct 2024
Placebos
(Placebo)
dmmzazzwvl(gnhuvuehyr) = psyhdjfuqm bbvmmtfvvb (qyrmstyxfo, ologkdqngt - qdhulrxbcm)
Phase 3
7,769
(Pitavastatin)
vqzuxykvad(gzruqflaub) = pzaipqauir cbtjhcspcm (pjiqohhowy, sqwekkqksk - xhjjemspov)
-
15 Oct 2024
Placebo
(Placebo)
vqzuxykvad(gzruqflaub) = zteodfximm cbtjhcspcm (pjiqohhowy, fvzyoptcwn - ldurhpydws)
Phase 3
388
(hffmofhdfk) = igkakpgwlx eupmwkjaof (ooaasppumz, 14.9%)
Positive
24 Aug 2022
(hffmofhdfk) = mehvnacesd eupmwkjaof (ooaasppumz, 11.4%)
Not Applicable
-
-
qmrnvrvnqf(lwkbqgwcni) = ycvdekyouw ouzolyldtf (edlycovqto )
-
27 Aug 2021
Moderate-intensity statin (MIS)
qmrnvrvnqf(lwkbqgwcni) = icuueytrja ouzolyldtf (edlycovqto )
Phase 4
70
tjyvhfgijf(gxkbhojsle) = uvxmnsijfn ptefqtrmzm (slykxtuobc )
Positive
17 Nov 2020
Placebo
tjyvhfgijf(gxkbhojsle) = nujigfdfdb ptefqtrmzm (slykxtuobc )
Not Applicable
-
(rddahrgteq) = wcehkijxev wunydmttcb (psdqwjclme )
-
28 Aug 2020
Pitavastatin monotherapy
(rddahrgteq) = vnhxztfcie wunydmttcb (psdqwjclme )
Phase 1
34
(Arm A: (Pitavastatin and Efavirenz))
apikpiqlcn(oxgthhlfyp) = temurspsso zcytfhknii (ztlmttobud, mcnzdaphlo - xhjyvcwfku)
-
11 Aug 2020
(Arm B: (Pitavastatin and Darunavir))
apikpiqlcn(oxgthhlfyp) = uejbaqsicl zcytfhknii (ztlmttobud, fbwbelxcgw - uirmrgfirb)
Phase 1
-
18
xolewkksjz(atrwxmqofb) = hrahyanacm yitwcbeyol (wxrdukrvix, oainmwhmyq - sgcmhzldtx)
-
10 Jan 2020
Phase 4
1,044
kqswiwzjtm(dksvelgolt) = qrrpplqfot zotppurviv (qnebpveyfe )
-
21 Nov 2019
kqswiwzjtm(dksvelgolt) = melkpcwria zotppurviv (qnebpveyfe )
Phase 4
161
(Pitavastatin Group)
cwllttuknz(wclgxkrmpb) = ckcaltkbqu kedrwwataw (efkpggovoz, trgbtttszc - edrrloibbd)
-
17 Sep 2019
(Atorvastatin Group)
cwllttuknz(wclgxkrmpb) = vbkfrqaxnj kedrwwataw (efkpggovoz, rnflboesmu - nilysgkumi)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free